| Compounds, compositions and methods for the treatment of disease |
2022-5-12 |
2022-7-20 |
|
| Lag-3 binding members |
2022-3-28 |
2022-6-16 |
|
| Binding molecules binding pd-l1 and lag-3 |
2022-3-28 |
2022-6-28 |
|
| Multispecific anti-tcr delta variable 1 antibodies |
2022-2-17 |
2022-8-25 |
|
| Dosage regimes for the administration of a lag-3/pd-l1 bispecific antibody |
2021-11-10 |
2022-1-01 |
|
| COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE |
2021-10-01 |
2021-11-30 |
|
| Method for engineering immunoglobulins |
2021-2-16 |
2021-12-16 |
|
| Synthetic immunoglobulin domains with binding properties engineered in regions … |
2019-11-22 |
2022-11-15 |
2022-11-15 |
| Mesothelin and CD137 binding molecules |
2019-7-12 |
2021-3-11 |
|
| Fc-binding fragment comprising OX40 antigen binding site |
2019-7-12 |
2021-4-30 |
|
| FC binding fragments comprising a CD137 antigen-binding site |
2019-7-12 |
2021-3-04 |
|
| Antibody molecules that bind to PD-L1 and CD137 |
2019-7-12 |
2021-2-26 |
|
| Antibody molecules that bind cd137 and ox40 |
2019-7-12 |
2021-5-19 |
|
| Anti-cd137 antibodies |
2019-7-12 |
2021-8-05 |
|
| Antibody molecules |
2019-7-12 |
2021-9-30 |
|
| Anti-mesothelin antibodies. |
2019-7-12 |
2021-5-27 |
|
| Compounds, compositions, and methods for the treatment of disease |
2019-7-08 |
2021-5-19 |
|
| Nucleotide and oligonucleotide prodrugs |
2019-5-23 |
2020-3-19 |
|
| FC binding fragments comprising a PD-L1 antigen-binding site |
2018-12-19 |
2020-7-23 |
|
| Compounds, compositions, and methods for the treatment of disease |
2018-9-11 |
2020-8-27 |
|
| Compounds, compositions, and methods for the treatment of disease |
2018-9-11 |
2020-8-27 |
|
| Compounds, compositions, and methods for the treatment of disease |
2018-8-30 |
2019-3-07 |
|
| Design of short oligonucleotides as vaccine adjuvants and therapeutic agents |
2018-2-26 |
2018-6-07 |
|
| Conditional agonists of immune responses |
2018-1-09 |
2018-7-12 |
|
| Compositions and methods for the treatment of hbv infection |
2017-10-24 |
2019-9-26 |
|
| Design of oligonucleotide analogs as therapeutic agents |
2017-8-18 |
2018-1-18 |
|
| Novel multivalent immunoglobulins |
2017-8-15 |
2018-2-22 |
|
| Egfr binding molecules |
2017-7-19 |
2018-1-25 |
|
| EGFR binding molecules |
2017-7-19 |
2023-4-18 |
2023-4-18 |
| Compounds and compositions for the treatment of infections |
2017-3-10 |
2019-3-07 |
|
| Compositions and methods for treating viral infections |
2016-12-02 |
2019-8-13 |
2019-8-13 |
| Compositions and methods for the treatment of viral infection |
2016-7-01 |
2018-5-09 |
|
| Compositions and methods for the treatment of hcv infection |
2016-4-07 |
2019-2-14 |
|
| Compositions and methods for the treatment of hbv infection |
2016-4-07 |
2018-4-26 |
|
| Cytotoxic immunoglobulin |
2016-1-22 |
2016-6-23 |
|
| Display of binding agents |
2014-12-01 |
2015-6-04 |
|
| Methods and processes for attaching compounds to matrices |
2012-9-26 |
2013-3-28 |
|